SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports

被引:0
作者
Hibathulla Palapra
Subeesh K. Viswam
Vivekanandan Kalaiselvan
Krishna Undela
机构
[1] National Institute of Pharmaceutical Education and Research (NIPER) Guwahati,Department of Pharmacy Practice
[2] Manipal College of Pharmaceutical Sciences,Department of Pharmacy Practice
[3] Manipal Academy of Higher Education,undefined
[4] Indian Pharmacopoeia Commission,undefined
[5] Uttar Pradesh,undefined
来源
International Journal of Clinical Pharmacy | 2022年 / 44卷
关键词
Case reports; Detection; Disproportionality analysis; Pancreatitis; Pharmacovigilance; Signal; Sodium-glucose cotransporter-2 inhibitors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1425 / 1433
页数:8
相关论文
共 64 条
[21]  
von Hehn L(2016)Canagliflozin-associated acute pancreatitis Am J Ther 23 e972-undefined
[22]  
Herdegen T(2020)Adverse side effects: empagliflozin-related acute pancreatitis case report Cureus 12 e12325-undefined
[23]  
Murad MH(2021)An investigation on the association between sodium glucose co-transporter 2 inhibitors use and acute pancreatitis: a VigiBase study Pharmacoepidemiol Drug Saf 29 161-undefined
[24]  
Sultan S(2020)Pancreatic safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and meta-analysis Pharmacoepidemiol Drug Saf 19 1-undefined
[25]  
Haffar S(2019)SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT-2 inhibitors on plasma glucagon levels Mol Metab undefined undefined-undefined
[26]  
Badwal K(undefined)undefined undefined undefined undefined-undefined
[27]  
Tariq T(undefined)undefined undefined undefined undefined-undefined
[28]  
Peirce D(undefined)undefined undefined undefined undefined-undefined
[29]  
Chowdhary M(undefined)undefined undefined undefined undefined-undefined
[30]  
Kabbani AA(undefined)undefined undefined undefined undefined-undefined